HackeWZeumerHFerbertA. Intraarterial thrombolytic therapy improves outcome in patients with acute Vertebrobasilar occlusive disease. Stroke1988; 19:1216–22.
2.
FurlanAJHigashidaRWechslerL. Intra-arterial prourokinase for acute ischemic stroke-the PROACT II study: a randomized controlled trial. JAMA1992; 282:2003–11.
3.
HigashidaRTFurlanAJ. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke2003; 34(8):e109–37.
4.
BroderickJPPaleschYYDemchukAM. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med2013; 368:893–903.
5.
KidwellCSJahanRGornbeinJ. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med2013; 368:914–23.
6.
CicconeCValvassorLJNichelattiM. Endovascular treatment for acute ischemic stroke. N Engl J Med2013; 368:924–32.
7.
ChimowitzMI. Endovascular treatment for acute ischemic stroke – still unproven. N Engl J Med2013; 368:952–5.
8.
SaverJLRezaJLevyEI. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet2012; 380:1231–40.
9.
NogueiraRGJovinTGAlbersGW. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet2012; 380:1241–9.
10.
Lansberg MG, Straka M, Kemp S et al. for the DEFUSE 2 study investigators. *MRI profi le and response to endovascular reperfusion after-stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol2012; 11:860–67.
11.
HackeWFurlanAJAl-RawiY. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol2009; 8:141–50.
12.
DavisSMDonnanGAParsonsMW. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol2009; 7:299–309.
